top of page
Search
  • Ann Tucker
    • Mar 31
    • 1 min read

Study Shows High Prevalence of Buprenorphine 'Spiking' in Urine Screenings for OUD Patients

JAMA [3/28] | More than 7% of urine samples collected in a recent cross-sectional study [...] showed evidence of buprenorphine “spiking”—the intentional addition of buprenorphine tablet or residue directly into urine to mimic prescription adherence by opioid use disorder (OUD) patients. Cont.

0 views0 comments

Recent Posts

See All

DEA [3/22] | In a public safety alert, the DEA said it observed a sharp increase in the trafficking of fentanyl mixed with xylazine, a sedative also known as “Tranq” that has been approved by the Food

bottom of page